These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 29746)

  • 1. Fazadinium--a new neuromuscular blocking agent.
    Drug Ther Bull; 1978 Nov; 16(23):90-2. PubMed ID: 29746
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and pharmacological evaluation of imidazopyridinium derivatives as neuromuscular blocking agents.
    Bellani P; Clavenna G; Sosio A
    Farmaco Sci; 1984 Oct; 39(10):846-62. PubMed ID: 6510519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors limiting the rate of termination of the neuromuscular blocking action of fazadinium dibromide.
    Tyers MB
    Br J Pharmacol; 1978 Jun; 63(2):287-93. PubMed ID: 27272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between pharmacokinetics and pharmacodynamics of fazadinium in rabbits.
    Dominguez-Gil AA; Cepeda M; Muriel C; Calvo JI; Dominguez-Gil A; Alonso AC
    Arzneimittelforschung; 1981; 31(11):1913-7. PubMed ID: 6119095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuromuscular block induced by fazadinium. Electrophysiological study on fast and slow muscles in the rabbit].
    Dattola R; Praticò C; Girlanda P; Vita G; Venuto C; Venuti FS; Montanini S; Messina C
    Minerva Anestesiol; 1984; 50(7-8):379-82. PubMed ID: 6151630
    [No Abstract]   [Full Text] [Related]  

  • 6. Fazadinium in anaesthesia.
    Rowlands DE; Fidler K
    Br J Anaesth; 1978 Mar; 50(3):289-93. PubMed ID: 25077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacology of fazadinium (AH 8165)].
    Kienlen J; du Callar J
    Ann Anesthesiol Fr; 1981; 22(6):631-9. PubMed ID: 6124193
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new non-depolarizing relaxant agent: AH 8165 D (fazadinium dibromide)].
    Cabarrocas Gafarot E; Barbero Carballo MC; Cortés Forteza C; Rodríguez Moñinos A; Comas Arroyo ML
    Rev Esp Anestesiol Reanim; 1979 Mar; 26(2):99-110. PubMed ID: 38489
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between decay of plasma concentration of fazadinium and recovery from its neuromuscular blocking effect.
    d'Hollander AA; Duvaldestin P; Henzel D; Delcroix C; Desmonts JM
    Br J Anaesth; 1981 Aug; 53(8):853-8. PubMed ID: 6115662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of single twitch and train-of-four responses and of tetanic fade in relation to plasma concentrations of fazadinium in man.
    d'Hollander AA; Duvaldestin P; Delcroix C; Nevelsteen M; Desmonts JM
    Anesth Analg; 1982 Mar; 61(3):225-30. PubMed ID: 6121521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of recovery from fazadinium: relationship to the rate of decline of its plasma concentration.
    Ramzan IM
    J Pharm Sci; 1983 Nov; 72(11):1369-70. PubMed ID: 6139474
    [No Abstract]   [Full Text] [Related]  

  • 12. Analytical model of some pharmacokinetic and pharmacodynamic properties of fazadinium in man.
    d'Hollander AA; Delcroix C; Duvaldestin P; Henzel D; Coussaert E; Desmonts JM
    Eur J Clin Pharmacol; 1983; 24(3):407-13. PubMed ID: 6134623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fazadinium and presynaptic effects].
    González Miranda F; Pascual del Riquelme y Viudes R
    Rev Esp Anestesiol Reanim; 1987; 34(5):396-8. PubMed ID: 2891159
    [No Abstract]   [Full Text] [Related]  

  • 14. AH 8165: a new short-acting, competitive neuromuscular blocking drug.
    Brittain RT; Tyers MB
    Br J Pharmacol; 1972 May; 45(1):158P-159P. PubMed ID: 4625270
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic effects of a new antidepolarizing agent: fazadinium bromide].
    Pinaud M; Rochedreux A; Dixneuf B; Nicolas F
    Anesth Analg (Paris); 1978; 35(6):1023-32. PubMed ID: 38682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary report on the AH 8.165 (1-1'azo bis-3-methyl-2-phenyl-1H-imidazo 1,2-A) pyridinium dibromate].
    Dávalos Sánchez R; Belda Mendoza J; Salort Vives J
    Rev Esp Anestesiol Reanim; 1978 Jan; 25(1):68-73. PubMed ID: 30120
    [No Abstract]   [Full Text] [Related]  

  • 17. Fazadinium--a new formulation.
    Buckley P; Scott DB
    Br J Anaesth; 1977 Feb; 49(2):191-2. PubMed ID: 13804
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blocking of the neuromuscular conduction by decamethylene-bis-pyridinium].
    Danilov AF
    Farmakol Toksikol; 1970; 33(5):536-8. PubMed ID: 4250151
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical neuromuscular pharmacology of AH 8165 D, an azobis-arylimidazo-pyridinium-compound.
    Schuh FT
    Anaesthesist; 1975 Apr; 24(4):151-6. PubMed ID: 237423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical study on vecuronium in children: a comparison with fazadinium and pancuronium.
    Esener Z
    Turk J Pediatr; 1988; 30(3):163-72. PubMed ID: 2907392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.